Aligos Therapeutics Inc. logo

Aligos Therapeutics Inc. (ALGS)

Market Closed
14 Sep, 20:00
NASDAQ (CM) NASDAQ (CM)
$
5. 04
-0.18
-3.4483%
$
32.3M Market Cap
- P/E Ratio
- Div Yield
28,021 Volume
-10.36 Eps
$ 5.22
Previous Close
Add Transaction
Day Range
5.02 5.27
Year Range
3.98 13.69
Want to track ALGS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Aligos Therapeutics Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
John H. Burbank III
John H. Burbank III Passport Capital LLC
83,055 $719,256 $431,055.45 -$288,200.55 -40.07%
NM
Nir Messafi Deep Track Capita LLP
444,110 $3.76M $2.24M -$1.53M -40.53%
Andrew Kirchner
Andrew Kirchner ELEVATION WEALTH PARTNERS, LLC
4 $35 $23.56 -$11.44 -32.69%
MA
Marie-Andree Alain Federation des caisses Desjardins du Quebec
4,650 $25,966 $32,038.5 $6,072.5 23.39%